BioLight announced today that it has received approval from the U.S. Securities and Exchange Commission (SEC) to commence its American Depository Receipt (ADR) program.
Over-the-counter (OTC) trading in the BioLight ADR Level 1 will commence on January 22 under the ticker symbol “BLGTY” (CUSIP Number: 09072W103).
Each ADR will be comprised of 100 ordinary shares of BioLight.
Link to Newsroom